Clinical trial leads to a decrease in early deaths from rare and aggressive acute promyelocytic leukemia (APL)
The use of a simplified treatment regimen by oncologists, along with management recommendations and 24/7 support provided by a limited and dedicated group of academic disease experts, resulted in a dramatic decrease in early ...